Table 3 |
|||||
|
Results of MSA analysis for 11 replicate sets from GAW13 |
|||||
|
Replicate |
Number of Cases |
Number of Controls |
85% quantile (mg/ml) |
15% quantile (mg/ml) |
Poverall |
|
|
|||||
|
1 |
132 |
121 |
210 |
156 |
0.443 |
|
2 |
142 |
92 |
211 |
156 |
0.945 |
|
3 |
124 |
103 |
210 |
157 |
0.802 |
|
4 |
141 |
112 |
211 |
157 |
0.082 |
|
5 |
150 |
103 |
210 |
157 |
0.112 |
|
6 |
140 |
105 |
209 |
155 |
0.148 |
|
7 |
125 |
128 |
210 |
155 |
0.481 |
|
8 |
146 |
111 |
209 |
156 |
0.095 |
|
9 |
124 |
121 |
210 |
154 |
0.694 |
|
10 |
142 |
94 |
209 |
156 |
0.744 |
|
26 |
125 |
105 |
210 |
155 |
0.542 |
|
|
|||||
|
Kim et al. BMC Genetics 2003 4(Suppl 1):S9 doi:10.1186/1471-2156-4-S1-S9 |
|||||